Michelle A Mollica1, Kathryn E Weaver2, Timothy S McNeel3, Erin E Kent1. 1. Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, Maryland. 2. Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina. 3. Information Management Services, Inc, Rockville, Maryland.
Abstract
BACKGROUND: Rural cancer patients often have challenges in accessing quality care. This study examined associations between the place of residence at cancer diagnosis (urban vs rural) and patient ratings of access to care among older cancer survivors participating in Medicare-managed care. METHODS: Using Surveillance, Epidemiology, and End Results -Consumer Assessment of Healthcare Providers and Systems (SEER-CAHPS) linked data, which included SEER data and Medicare CAHPS patient experience surveys, this study identified urban (n = 6140) and rural Medicare beneficiaries (n = 686) aged ≥ 65 years with a breast, lung, colorectal, or prostate cancer diagnosis who had completed a Medicare CAHPS survey between 1998 and 2013. Multivariable models examined associations between survivor residence at the time of diagnosis and CAHPS measures of timeliness and ease of getting care. RESULTS: Respondents who resided in urban areas (vs rural) at the time of their cancer diagnosis rated their care significantly lower for Getting Care Quickly (b = -2.27; standard error = 0.95; P = .02). Although there were no overall significant differences for Getting Needed Care, there was a significant interaction between race/ethnicity and residence (P = .04): both non-Hispanic black and Hispanic respondents residing in rural areas rated Getting Needed Care lower than those respondents residing in urban areas. CONCLUSIONS: In contrast to prior studies, these findings suggest that rural survivors report more timely care than those in urban areas, but accessing needed care may be more challenging for racial/ethnic minority rural survivors. Future examination of specific barriers for urban and racial/ethnic minority rural survivors is warranted to ensure equitable access to quality cancer care. Cancer 2018.
BACKGROUND: Rural cancerpatients often have challenges in accessing quality care. This study examined associations between the place of residence at cancer diagnosis (urban vs rural) and patient ratings of access to care among older cancer survivors participating in Medicare-managed care. METHODS: Using Surveillance, Epidemiology, and End Results -Consumer Assessment of Healthcare Providers and Systems (SEER-CAHPS) linked data, which included SEER data and Medicare CAHPS patient experience surveys, this study identified urban (n = 6140) and rural Medicare beneficiaries (n = 686) aged ≥ 65 years with a breast, lung, colorectal, or prostate cancer diagnosis who had completed a Medicare CAHPS survey between 1998 and 2013. Multivariable models examined associations between survivor residence at the time of diagnosis and CAHPS measures of timeliness and ease of getting care. RESULTS: Respondents who resided in urban areas (vs rural) at the time of their cancer diagnosis rated their care significantly lower for Getting Care Quickly (b = -2.27; standard error = 0.95; P = .02). Although there were no overall significant differences for Getting Needed Care, there was a significant interaction between race/ethnicity and residence (P = .04): both non-Hispanic black and Hispanic respondents residing in rural areas rated Getting Needed Care lower than those respondents residing in urban areas. CONCLUSIONS: In contrast to prior studies, these findings suggest that rural survivors report more timely care than those in urban areas, but accessing needed care may be more challenging for racial/ethnic minority rural survivors. Future examination of specific barriers for urban and racial/ethnic minority rural survivors is warranted to ensure equitable access to quality cancer care. Cancer 2018.
Authors: Whitney E Zahnd; Natoshia Askelson; Robin C Vanderpool; Lindsay Stradtman; Jean Edward; Paige E Farris; Victoria Petermann; Jan M Eberth Journal: Prev Med Date: 2019-08-15 Impact factor: 4.018
Authors: Lisa P Spees; Wendy R Brewster; Mahesh A Varia; Morris Weinberger; Christopher Baggett; Xi Zhou; Victoria M Petermann; Stephanie B Wheeler Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-02-07 Impact factor: 4.254
Authors: Courtney P Williams; Amy Davidoff; Michael T Halpern; Michelle Mollica; Kathleen Castro; Benjamin Allaire; Janet S de Moor Journal: JCO Oncol Pract Date: 2022-08
Authors: Whitney E Zahnd; Natalie Del Vecchio; Natoshia Askelson; Jan M Eberth; Robin C Vanderpool; Linda Overholser; Purnima Madhivanan; Rachel Hirschey; Jean Edward Journal: Health Serv Res Date: 2022-03-07 Impact factor: 3.734
Authors: Smita Bhatia; Wendy Landier; Electra D Paskett; Katherine B Peters; Janette K Merrill; Jonathan Phillips; Raymond U Osarogiagbon Journal: J Natl Cancer Inst Date: 2022-07-11 Impact factor: 11.816
Authors: Lucas K Vitzthum; Vinit Nalawade; Paul Riviere; Whitney Sumner; Tyler Nelson; Loren K Mell; Timothy Furnish; Brent Rose; María Elena Martínez; James D Murphy Journal: JCO Oncol Pract Date: 2021-02-03
Authors: Jacob A Clarke; Alyssa M Despotis; Ricardo J Ramirez; Jose P Zevallos; Angela L Mazul Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-07-29 Impact factor: 4.090
Authors: Alex Fauer; Lauren P Wallner; Matthew A Davis; Sung Won Choi; Christopher R Friese Journal: J Geriatr Oncol Date: 2020-09-20 Impact factor: 3.599
Authors: Alex Fauer; Sung Won Choi; Lauren P Wallner; Matthew A Davis; Christopher R Friese Journal: Cancer Causes Control Date: 2021-02-10 Impact factor: 2.506